These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 26011370

  • 1. Denosumab: Excellent response of metastatic giant cell tumor of the bone.
    Ulas A, Bulent Akinci M, Silay K, Sendur MA, Sener Dede D, Yalcin B.
    J BUON; 2015; 20(2):666-7. PubMed ID: 26011370
    [No Abstract] [Full Text] [Related]

  • 2. Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone.
    Gossai N, Hilgers MV, Polgreen LE, Greengard EG.
    Pediatr Blood Cancer; 2015 Jun; 62(6):1078-80. PubMed ID: 25556556
    [Abstract] [Full Text] [Related]

  • 3. Denosumab: a new treatment option for giant cell tumor of bone.
    Lewin J, Thomas D.
    Drugs Today (Barc); 2013 Nov; 49(11):693-700. PubMed ID: 24308016
    [Abstract] [Full Text] [Related]

  • 4. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
    Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, Jun S, Jacobs I.
    Clin Cancer Res; 2012 Aug 15; 18(16):4415-24. PubMed ID: 22711702
    [Abstract] [Full Text] [Related]

  • 5. Denosumab: a breakthrough in treatment of giant-cell tumour of bone?
    Balke M, Hardes J.
    Lancet Oncol; 2010 Mar 15; 11(3):218-9. PubMed ID: 20149737
    [No Abstract] [Full Text] [Related]

  • 6. Golden bullet-denosumab: early rapid response of metastatic giant cell tumor of the bone.
    Demirsoy U, Karadogan M, Selek Ö, Anik Y, Aksu G, Müezzinoglu B, Corapcioglu F.
    J Pediatr Hematol Oncol; 2014 Mar 15; 36(2):156-8. PubMed ID: 24072245
    [Abstract] [Full Text] [Related]

  • 7. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.
    Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, Dansey R, Jun S.
    Lancet Oncol; 2010 Mar 15; 11(3):275-80. PubMed ID: 20149736
    [Abstract] [Full Text] [Related]

  • 8. RANKL, denosumab, and giant cell tumor of bone.
    Thomas DM.
    Curr Opin Oncol; 2012 Jul 15; 24(4):397-403. PubMed ID: 22581354
    [Abstract] [Full Text] [Related]

  • 9. Neoadjuvant denosumab for extensive giant cell tumor in os ischium: a case report.
    van der Heijden L, van de Sande MA, Hogendoorn PC, Gelderblom H, Dijkstra PD.
    Acta Orthop; 2015 Jun 15; 86(3):393-5. PubMed ID: 25684041
    [No Abstract] [Full Text] [Related]

  • 10. Giant cell tumor of bone in childhood: clinical aspects and novel therapeutic targets.
    Federman N, Brien EW, Narasimhan V, Dry SM, Sodhi M, Chawla SP.
    Paediatr Drugs; 2014 Feb 15; 16(1):21-8. PubMed ID: 24114694
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of denosumab in giant-cell tumour of bone.
    Kyrgidis A, Toulis K.
    Lancet Oncol; 2010 Jun 15; 11(6):513-4. PubMed ID: 20522379
    [No Abstract] [Full Text] [Related]

  • 12. Safety of denosumab in giant-cell tumour of bone.
    Thomas D, Carriere P, Jacobs I.
    Lancet Oncol; 2010 Sep 15; 11(9):815. PubMed ID: 20816372
    [No Abstract] [Full Text] [Related]

  • 13. The clinical approach toward giant cell tumor of bone.
    van der Heijden L, Dijkstra PD, van de Sande MA, Kroep JR, Nout RA, van Rijswijk CS, Bovée JV, Hogendoorn PC, Gelderblom H.
    Oncologist; 2014 May 15; 19(5):550-61. PubMed ID: 24718514
    [Abstract] [Full Text] [Related]

  • 14. Denosumab: Current Use in the Treatment of Primary Bone Tumors.
    Savvidou OD, Bolia IK, Chloros GD, Papanastasiou J, Koutsouradis P, Papagelopoulos PJ.
    Orthopedics; 2017 Jul 01; 40(4):204-210. PubMed ID: 28732103
    [Abstract] [Full Text] [Related]

  • 15. Denosumab treatment of giant cell tumour of bone.
    Balke M.
    Lancet Oncol; 2013 Aug 01; 14(9):801-2. PubMed ID: 23867210
    [No Abstract] [Full Text] [Related]

  • 16. Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors.
    Lipton A, Balakumaran A.
    Expert Rev Clin Pharmacol; 2012 Jul 01; 5(4):359-71. PubMed ID: 22943116
    [Abstract] [Full Text] [Related]

  • 17. Denosumab for the treatment of giant cell tumor of the bone.
    Brodowicz T, Hemetsberger M, Windhager R.
    Future Oncol; 2015 Jul 01; 11(13):1881-94. PubMed ID: 26161925
    [Abstract] [Full Text] [Related]

  • 18. Denosumab: An Alternative Therapy for the Management of Giant Cell Lesions.
    O'Connell JE, Kearns GJ.
    J Oral Maxillofac Surg; 2016 May 01; 74(5):873. PubMed ID: 26899479
    [No Abstract] [Full Text] [Related]

  • 19. Giant cell tumour of bone.
    Thomas DM, Skubitz KM.
    Curr Opin Oncol; 2009 Jul 01; 21(4):338-44. PubMed ID: 19444102
    [Abstract] [Full Text] [Related]

  • 20. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J, Rosenberg AE, Bredella MA, Choy E, Hornicek FJ, Nielsen GP, Deshpande V.
    Am J Surg Pathol; 2016 Jan 01; 40(1):72-80. PubMed ID: 26414220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.